Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
Kathleen A LinderChristopher KovacsKate M MullaneCameron R WolfeNina M ClarkRicardo M La HozJeannina A SmithCamille Nelson KottonAjit P LimayeMaricar F MalinisMorgan HakkiAaron D MishkinArnoldo Adrian GonzalezMaria Dioverti PronoDarin OstranderRobin K AveryDaniel R KaulPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Patients treated with LET with viral load < 1000 IU/ml had good virologic outcomes. Outcomes were mixed when LET was initiated at higher viral loads. Further studies on combination therapy or alternative LET dosing are needed.